why choose us

Clinical Trials Search

Showing 15,010 of 132,963 result(s)
Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

Status: Completed

Condition: Retinal Disease

Interventions: IRX-101 is a novel ocular anti-septic

Date: 2023-02-17

Neonatal Intensive Care Unit Virtual Family-Centered Rounds

Status: Completed

Condition: Pediatric Disorder

Interventions:

Parents will be given the option to join FCR virtually or in-person; this intervention is changing the behavior of how providers deliver healthcare

Date: 2023-02-17

Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)

Status: Completed

Condition: Colon Adenocarcinoma

Interventions: Text messages will be sent to participants cell phones using the HealthySMS platform

Date: 2023-02-17

Motivation Skills Training for Schizophrenia

Status: ACTIVE_NOT_RECRUITING

Condition: Schizophrenia

Interventions: MST is a weekly group-based skills training intervention that aims to improve knowledge about one's level and sources of motivation, the ability

Date: 2023-02-17

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Status: Completed

Condition: Retinal Disease

Interventions: IRX-101 is a novel ocular anti-septic

Date: 2023-02-17

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors

Status: Completed

Condition: Locally Advanced Unresectable or Metastatic Solid Tumor

Interventions: SIM0237 should be administered intravenously at recommended dose qw or other dosing regimens

Date: 2023-02-17

The Long COVID-19 Wearable Device Study

Status: Completed

Condition: Long COVID

Interventions: The treatment group will receive their wearable device and the enhanced education at the start of the study.
Their outcomes will be compared with

Date: 2023-02-17

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Status: NOT_YET_RECRUITING

Condition: Acute Myeloid Leukemia

Interventions: There are 4 planned flat-dose levels: 25 × 10^6, 75 × 10^6 , 225 × 10^6 , and 450 × 10^6 CAR T cells and 1 de-escalation dose: 10 × 10^6 CAR T cells.

Date: 2023-02-17

Tranexamic Acid With Microneedling in Melasma

Status: NOT_YET_RECRUITING

Condition: Melasma

Interventions: 1 ml of TXA, available as a 500 mg;5 ml ampoule, will be applied on the right side of the face after microneedeling and left to dry

Date: 2023-02-17

Motor and Neurophysiological Changes After Ischemic Conditioning in Healthy and Individuals With Stroke

Status: NOT_YET_RECRUITING

Condition: Stroke

Interventions: While seated, a rapid inflation cuff, similar to those used to measure blood pressure, will be placed on the nondominant or paretic thigh to perform r

Date: 2023-02-17